ARK Investment Management LLC 13D and 13G filings for CRISPR Therapeutics AG:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 11:23 am Purchase |
2024-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 8,973,063 10.510% |
1,474,438 (+19.66%) |
Filing |
| 2025-01-10 9:23 pm Sale |
2024-09-30 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 7,498,625 8.800% |
-1,623,868 (-17.80%) |
Filing |
| 2024-12-10 1:34 pm Purchase |
2024-11-30 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 9,122,493 10.690% |
586,389 (+6.87%) |
Filing |
| 2024-01-29 4:00 pm Unchanged |
2023-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 8,536,104 10.750% |
0 (Unchanged) |
Filing |
| 2024-01-10 11:36 am Purchase |
2023-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 8,536,104 10.750% |
545,916 (+6.83%) |
Filing |
| 2023-04-10 9:17 pm Purchase |
2023-03-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 7,990,188 10.160% |
160,256 (+2.05%) |
Filing |
| 2023-02-10 12:25 pm Sale |
2022-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 7,829,932 10.000% |
-1,257,936 (-13.84%) |
Filing |
| 2022-02-09 2:29 pm Purchase |
2021-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 9,087,868 11.880% |
1,443,518 (+18.88%) |
Filing |
| 2021-09-10 2:47 pm Sale |
2021-08-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 7,644,350 10.030% |
-2,768,626 (-26.59%) |
Filing |
| 2021-02-16 4:33 pm Purchase |
2020-12-31 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 10,412,976 14.620% |
1,955,656 (+23.12%) |
Filing |
| 2020-10-09 1:51 pm Purchase |
2020-06-30 | 13G | CRISPR Therapeutics AG CRSP |
ARK Investment Management LLC | 8,457,320 12.050% |
8,457,320 (New Position) |
Filing |